Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials ; volume:271 ; number:5 ; day:13 ; month:4 ; year:2024 ; pages:2914-2916 ; date:5.2024
Journal of neurology ; 271, Heft 5 (13.4.2024), 2914-2916, 5.2024
- Creator
-
Guiloff, A. E.
Rudge, P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-024-12361-w
- URN
-
urn:nbn:de:101:1-2407111538470.234255669078
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guiloff, A. E.
- Rudge, P.
- SpringerLink (Online service)
Other Objects (12)
A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer’s Disease
Automated detection of early-stage Alzheimer’s Disease
A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease
A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice
Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer’s Disease
Automated detection of early-stage Alzheimer’s Disease
A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease
A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice
Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer’s Disease
Automated detection of early-stage Alzheimer’s Disease
A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease
A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice
Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease